FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955312899> ?p ?o ?g. }

• W2955312899 endingPage "2155" @default.
• W2955312899 startingPage "2155" @default.
• W2955312899 abstract "Abstract Background: CIVO microdosing studies performed in patient tumors in situ allow drug developers to assess localized tumor and microenvironment responses to multiple agents without having to expose patients to high systemic drug levels. By concentrating microdoses of multiple different drugs within a living tumor in situ, it is possible to compare tumor and immune responses in spatially resolved regions of the same tumor. This type of early phase (Phase 0) clinical study represents a new path for drug developers to gain insight into drug efficacy, tumor associated immune cell modulation, biomarker discovery and validation, and microenvironment interactions for new drugs earlier in the drug development process. Traditionally, analysis of FFPE samples from these microdosing studies involve routine immunohistochemistry, immunofluorescence, and in situ assays that reveal changes in protein and RNA expression. These assays offer tissue wide protein and gene expression information but have limited multiplexing capabilities and dynamic range, as well as rapidly consume precious trial samples. Novel technologies such as NanoString’s GeoMxTM Digital Spatial Profiler (DSP) enable high-plex spatially resolved analysis of proteins and RNA transcripts in single FFPE tissue sections. In this proof of principle study, we utilized GeoMxTM Digital Spatial Profiler for protein and RNA expression on single FFPE sections from patient sarcoma tumors that were microdosed with multiple FDA approved drugs. Methods: Single FFPE sections from microdosed patient tumor samples were IF stained for DNA and CD3 and whole slide imaged. 600-micron and 100-micron diameter regions of interests (ROIs) were selected for DSP analysis within drug and control microinjection sites. Imaging and barcode counts were performed using GeoMxTM DSP and nCounter systems. Results: DSP protein analysis highlighted phospho-S6 and phospho-ERK upregulation in response to doxorubicin compared to vehicle site. Additionally, ROIs sampled along the doxorubicin exposure gradient showed a dose-dependent reduction of phosphorylation of both S6 and ERK proteins. DSP RNA analysis revealed drug specific transcript regulation of multiple genes in microdosed tumors, including upregulation of chemokines CXCL9 and CXCL10 at sites of doxorubicin and aldesleukin injection but not to other chemotherapy agents. Conclusions: Early phase CIVO microdosing studies combined with high-plex DSP opens the door to generating multi-omics data for multiple microdosed drugs within small patient studies. Analysis of protein and RNA expression using DSP enabled collection of targeted region of interest high density data from single FFPE sections, conserving precious patient biopsy samples. Through continued expansion of the GeoMxTM DSP analyte panels, collecting an ever-increasing depth of protein and gene expression data is possible in Phase 0 CIVO microdosing studies. Citation Format: Gary B. Deutsch, Seth M. Pollack, Matthew J. Thompson, Kenneth R. Gundle, Jessica A. Bertout, Jason P. Frazier, Emily Beirne, Marc O. Grenley, JingJing Gong, Yan Liang, Joseph M. Beechem, Richard A. Klinghoffer, Robert G. Maki. High-plex spatial profiling analysis of multidrug CIVO microdose studies in cancer patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2155." @default.
• W2955312899 created "2019-07-12" @default.
• W2955312899 creator A5001855528 @default.
• W2955312899 creator A5012138398 @default.
• W2955312899 creator A5026451121 @default.
• W2955312899 creator A5038549895 @default.
• W2955312899 creator A5045828406 @default.
• W2955312899 creator A5056548473 @default.
• W2955312899 creator A5060511465 @default.
• W2955312899 creator A5062118013 @default.
• W2955312899 creator A5062917416 @default.
• W2955312899 creator A5064399257 @default.
• W2955312899 creator A5068677359 @default.
• W2955312899 creator A5070065201 @default.
• W2955312899 creator A5072477568 @default.
• W2955312899 date "2019-07-01" @default.
• W2955312899 modified "2023-10-02" @default.
• W2955312899 title "Abstract 2155: High-plex spatial profiling analysis of multidrug CIVO microdose studies in cancer patients" @default.
• W2955312899 doi "https://doi.org/10.1158/1538-7445.am2019-2155" @default.
• W2955312899 hasPublicationYear "2019" @default.
• W2955312899 type Work @default.
• W2955312899 sameAs 2955312899 @default.
• W2955312899 citedByCount "0" @default.
• W2955312899 crossrefType "journal-article" @default.
• W2955312899 hasAuthorship W2955312899A5001855528 @default.
• W2955312899 hasAuthorship W2955312899A5012138398 @default.
• W2955312899 hasAuthorship W2955312899A5026451121 @default.
• W2955312899 hasAuthorship W2955312899A5038549895 @default.
• W2955312899 hasAuthorship W2955312899A5045828406 @default.
• W2955312899 hasAuthorship W2955312899A5056548473 @default.
• W2955312899 hasAuthorship W2955312899A5060511465 @default.
• W2955312899 hasAuthorship W2955312899A5062118013 @default.
• W2955312899 hasAuthorship W2955312899A5062917416 @default.
• W2955312899 hasAuthorship W2955312899A5064399257 @default.
• W2955312899 hasAuthorship W2955312899A5068677359 @default.
• W2955312899 hasAuthorship W2955312899A5070065201 @default.
• W2955312899 hasAuthorship W2955312899A5072477568 @default.
• W2955312899 hasConcept C104317684 @default.
• W2955312899 hasConcept C126322002 @default.
• W2955312899 hasConcept C142724271 @default.
• W2955312899 hasConcept C150194340 @default.
• W2955312899 hasConcept C2776107976 @default.
• W2955312899 hasConcept C2777609662 @default.
• W2955312899 hasConcept C2780913584 @default.
• W2955312899 hasConcept C3020616263 @default.
• W2955312899 hasConcept C502942594 @default.
• W2955312899 hasConcept C55493867 @default.
• W2955312899 hasConcept C62478195 @default.
• W2955312899 hasConcept C70721500 @default.
• W2955312899 hasConcept C71924100 @default.
• W2955312899 hasConcept C81439078 @default.
• W2955312899 hasConcept C86554907 @default.
• W2955312899 hasConcept C86803240 @default.
• W2955312899 hasConceptScore W2955312899C104317684 @default.
• W2955312899 hasConceptScore W2955312899C126322002 @default.
• W2955312899 hasConceptScore W2955312899C142724271 @default.
• W2955312899 hasConceptScore W2955312899C150194340 @default.
• W2955312899 hasConceptScore W2955312899C2776107976 @default.
• W2955312899 hasConceptScore W2955312899C2777609662 @default.
• W2955312899 hasConceptScore W2955312899C2780913584 @default.
• W2955312899 hasConceptScore W2955312899C3020616263 @default.
• W2955312899 hasConceptScore W2955312899C502942594 @default.
• W2955312899 hasConceptScore W2955312899C55493867 @default.
• W2955312899 hasConceptScore W2955312899C62478195 @default.
• W2955312899 hasConceptScore W2955312899C70721500 @default.
• W2955312899 hasConceptScore W2955312899C71924100 @default.
• W2955312899 hasConceptScore W2955312899C81439078 @default.
• W2955312899 hasConceptScore W2955312899C86554907 @default.
• W2955312899 hasConceptScore W2955312899C86803240 @default.
• W2955312899 hasIssue "13_Supplement" @default.
• W2955312899 hasLocation W29553128991 @default.
• W2955312899 hasOpenAccess W2955312899 @default.
• W2955312899 hasPrimaryLocation W29553128991 @default.
• W2955312899 hasRelatedWork W1583029732 @default.
• W2955312899 hasRelatedWork W2054836553 @default.
• W2955312899 hasRelatedWork W2113548725 @default.
• W2955312899 hasRelatedWork W3023962864 @default.
• W2955312899 hasRelatedWork W3162232665 @default.
• W2955312899 hasRelatedWork W4361896672 @default.
• W2955312899 hasRelatedWork W4361896681 @default.
• W2955312899 hasRelatedWork W4362594752 @default.
• W2955312899 hasRelatedWork W4380450124 @default.
• W2955312899 hasRelatedWork W4385457993 @default.
• W2955312899 hasVolume "79" @default.
• W2955312899 isParatext "false" @default.
• W2955312899 isRetracted "false" @default.
• W2955312899 magId "2955312899" @default.
• W2955312899 workType "article" @default.